loratadine
Claritin (loratadine) is a second-generation, long-acting H1 receptor antagonist (antihistamine) indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and children aged 2 years and older. Unlike first-generation antihistamines, loratadine is peripherally selective and does not readily cross the blood-brain barrier at recommended doses, resulting in minimal sedation and anticholinergic effects. It works by selectively blocking peripheral histamine H1 receptors, thereby preventing the vasodilation, increased vascular permeability, and pruritus triggered by histamine release from mast cells and basophils. The FDA approved loratadine as a prescription product in 1993 and it transitioned to over-the-counter status in 2002, making it one of the most widely used non-sedating antihistamines in the United States.
Medically reviewed by MedCentralHub Medical Review Board, Licensed Pharmacists & Physicians ·
Quick Reference

Claritin (loratadine) is a second-generation, long-acting H1 receptor antagonist (antihistamine) indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and children aged 2 years and older. Unlike first-generation antihistamines, loratadine is peripherally selective and does not readily cross the blood-brain barrier at recommended doses, resulting in minimal sedation and anticholinergic effects. It works by selectively blocking peripheral histamine H1 receptors, thereby preventing the vasodilation, increased vascular permeability, and pruritus triggered by histamine release from mast cells and basophils. The FDA approved loratadine as a prescription product in 1993 and it transitioned to over-the-counter status in 2002, making it one of the most widely used non-sedating antihistamines in the United States.
Claritin (loratadine) belongs to the Second-generation antihistamine (H1 receptor antagonist) class of medications. It was first approved by the FDA in . This medication is available over-the-counter without a prescription.
This is a summary only. Always read the full prescribing information and consult your healthcare provider for personalized medical advice.
Claritin is prescribed for the following conditions. Some uses are FDA-approved indications; others may be evidence-based off-label uses. Consult your healthcare provider for personalized guidance.

The following are general dosing guidelines only. Your actual dose should be determined by your healthcare provider based on your condition, renal/hepatic function, and other medications.
10 mg orally once daily. For patients with hepatic impairment (any degree) or renal impairment (GFR <30 mL/min): reduce to 10 mg every other day. Maximum recommended dose is 10 mg per 24-hour period. No dose adjustment required based on age alone in otherwise healthy adults.
Children 2 to 5 years: 5 mg (syrup or chewable tablet) once daily. Children 6 years and older: 10 mg once daily (same as adult dosing). Not recommended for infants under 2 years of age without direct physician supervision. For children with hepatic or renal impairment: use every-other-day dosing.
Available Forms
Available Strengths


Always inform your healthcare provider and pharmacist about ALL medications you take, including prescriptions, OTC medicines, vitamins, and supplements.
Hepatic impairment: Loratadine is extensively metabolized by the liver to its active metabolite descarboethoxyloratadine (desloratadine). Patients with any degree of hepatic impairment should use 10 mg every other day; severe impairment may require further monitoring and dose reduction
Renal impairment: In patients with GFR <30 mL/min, reduce dosing frequency to every other day (10 mg every 48 hours) to prevent accumulation of the active metabolite
Hypersensitivity: Contraindicated in patients with known hypersensitivity to loratadine or any component of the formulation; cross-reactivity within the piperidine antihistamine class is possible
Claritin-D (loratadine/pseudoephedrine) — cardiovascular risks: The pseudoephedrine component is contraindicated in patients with severe hypertension, severe coronary artery disease, or those taking MAO inhibitors within 14 days due to risk of hypertensive crisis and cardiac events
Claritin-D — urinary retention: Pseudoephedrine-containing formulations should be used with extreme caution in males with benign prostatic hyperplasia (BPH) due to risk of acute urinary retention
Narrow-angle glaucoma: The pseudoephedrine-containing Claritin-D formulations should be avoided in patients with narrow-angle glaucoma; plain loratadine has minimal anticholinergic effects and is generally safe
Pregnancy: Category B — loratadine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus; epidemiological data have not demonstrated increased risk of major malformations
Breastfeeding: Loratadine and its active metabolite are excreted in human breast milk in small amounts; the clinical decision to discontinue breastfeeding or the drug should account for the infant's age, maternal benefit, and level of drug exposure
Pediatric use (under 2 years): Safety and efficacy have not been established in children under 2 years of age; do not use without direct medical supervision in this age group
Drug interactions with CYP inhibitors: Concurrent use of strong CYP3A4 or CYP2D6 inhibitors can markedly increase loratadine plasma concentrations; dose adjustment or closer monitoring is required in such patients
Phenylketonuria (PKU): Some chewable tablet formulations and orally disintegrating tablet formulations contain aspartame, which metabolizes to phenylalanine — patients with PKU should avoid these formulations and select alternative dosage forms
Not a treatment for anaphylaxis: Loratadine is not indicated for, and should not be used as, primary treatment for anaphylaxis or other severe acute allergic reactions; epinephrine remains the first-line treatment for anaphylaxis

Loratadine exerts its antiallergic effects by selectively and competitively antagonizing peripheral histamine H1 receptors, preventing histamine from binding and triggering downstream inflammatory cascades that cause vasodilation, increased capillary permeability, smooth muscle contraction, and pruritus. Unlike first-generation antihistamines such as diphenhydramine, loratadine's tricyclic piperidine structure confers high peripheral receptor selectivity and low lipophilicity, significantly reducing its ability to cross the blood-brain barrier and occupy central H1 receptors at standard therapeutic doses, thereby minimizing sedation. Loratadine is a prodrug that undergoes extensive first-pass hepatic metabolism to its pharmacologically active metabolite, descarboethoxyloratadine (desloratadine), which contributes substantially to the drug's clinical antihistaminic activity and prolonged duration of action.

Consult your healthcare provider.
Full Pregnancy InformationMany medications pass into breast milk in varying amounts. Before using Claritinwhile breastfeeding, discuss the benefits and risks with your healthcare provider or pharmacist — they can weigh your dose, your infant's age, and available lactation safety data to find the safest option for you and your baby.

Store at controlled room temperature between 68°F and 77°F (20°C to 25°C); excursions permitted between 59°F and 86°F (15°C to 30°C). Protect from excessive moisture and direct light. Keep out of reach of children. Do not store in bathroom medicine cabinets due to humidity. Oral syrup should be stored upright at room temperature and used within the manufacturer-specified period after opening (typically 1 year). Orally disintegrating tablets (RediTabs) should be kept in their original blister pack until time of use to prevent moisture exposure and premature dissolution.
Claritin (loratadine) is classified as a non-drowsy antihistamine because at the recommended dose of 10 mg, it does not readily cross the blood-brain barrier. However, approximately 8% of users report some degree of drowsiness, particularly at higher doses or when combined with alcohol or other CNS depressants. Most people find Claritin far less sedating than first-generation antihistamines like Benadryl (diphenhydramine).
Yes, Claritin is safe for daily long-term use at the recommended dose. It is widely used throughout allergy seasons, which may last weeks to months, and many patients with perennial (year-round) allergic rhinitis take it continuously. There is no evidence of tolerance (tachyphylaxis) developing with regular use. However, always consult your doctor or pharmacist if you need guidance on long-term use, especially if you have kidney or liver disease.
The most clinically significant Claritin drug interactions involve medications that inhibit CYP3A4 or CYP2D6 liver enzymes, such as ketoconazole, erythromycin, cimetidine, and certain antidepressants (fluoxetine, paroxetine). These drugs can increase loratadine blood levels by 40–70%, potentially raising the risk of side effects. Claritin-D (which contains pseudoephedrine) should never be combined with MAO inhibitors. Alcohol can enhance drowsiness. Always tell your healthcare provider about all medications and supplements you are taking.
Loratadine is classified as FDA Pregnancy Category B, meaning animal studies have not shown fetal harm, and several large epidemiological studies in pregnant women have not found an increased risk of major birth defects. It is generally considered one of the preferred antihistamines during pregnancy when allergy treatment is necessary. However, you should always consult your obstetrician before taking any medication during pregnancy, especially during the first trimester.
Claritin begins to work within 1 to 3 hours after taking an oral dose, with peak antihistamine effects occurring at approximately 8 to 12 hours. The full duration of action lasts up to 24 hours, which is why it is dosed once daily. For best results with predictable allergen exposure (such as visiting a pet owner's home), taking Claritin 1 to 2 hours before exposure is advisable.
Regular Claritin contains only loratadine (10 mg), which addresses sneezing, itching, runny nose, and hives. Claritin-D adds pseudoephedrine (a nasal decongestant) to also relieve nasal congestion. Claritin-D is more effective for severe nasal stuffiness but carries additional risks, including elevated blood pressure, increased heart rate, insomnia, and urinary retention. It is also regulated under the Combat Methamphetamine Epidemic Act and requires purchase from behind the pharmacy counter with ID.
Yes. Claritin is FDA-approved for children aged 2 years and older. Children ages 2 to 5 receive 5 mg once daily (syrup or chewable tablet), while children 6 and older take the full adult dose of 10 mg once daily. Claritin should not be given to infants under 2 years without direct medical supervision. The syrup formulation is convenient for young children who cannot swallow tablets.
Taking Claritin (loratadine) and Zyrtec (cetirizine) together is generally not recommended, as both are H1 antihistamines with the same mechanism of action. Combining them does not provide additional allergy relief and may increase the risk of side effects such as drowsiness and dry mouth. If one antihistamine is not adequately controlling your symptoms, speak to your doctor — they may recommend switching products, adjusting doses, or adding a nasal steroid spray for better allergy control.
Second-generation antihistamine (H1 receptor antagonist) alternatives
Compare all Second-generation antihistamine (H1 receptor antagonist) medications — uses, side effects, and cost differences
Claritin dosage guide
Adult, pediatric, renal, and hepatic dosing for Claritin
Claritin side effects
Complete adverse effect profile including common, serious, and rare reactions
Claritin drug interactions
Full interaction list with severity ratings for Claritin
Seasonal allergic rhinitis treatment options
Medications, lifestyle changes, and clinical guidance for Seasonal allergic rhinitis
Perennial allergic rhinitis treatment options
Medications, lifestyle changes, and clinical guidance for Perennial allergic rhinitis
Chronic idiopathic urticaria treatment options
Medications, lifestyle changes, and clinical guidance for Chronic idiopathic urticaria
## What Is Claritin (Loratadine)?
Claritin is the brand name for loratadine, a widely used second-generation antihistamine available over the counter in the United States and many other countries. Approved by the FDA as a prescription drug in 1993 and switched to OTC status in 2002, loratadine has become one of the best-selling allergy medications in the world due to its proven efficacy and favorable non-sedating profile. It is used by millions of adults and children every year to manage the sneezing, runny nose, itchy eyes, and skin reactions caused by allergies.
Unlike older antihistamines such as diphenhydramine (Benadryl), Claritin does not commonly cause drowsiness at recommended doses because it does not easily cross into the brain. This makes it a preferred choice for people who need allergy relief while remaining alert at work, school, or while driving.
---
## How Does Claritin Work?
Claritin works by blocking histamine H1 receptors throughout the body. When you encounter an allergen — pollen, pet dander, dust mites, mold, or certain foods — your immune system triggers the release of histamine from mast cells and basophils. Histamine binds to H1 receptors in the nose, eyes, skin, and airways, causing the familiar allergy symptoms: sneezing, itching, watery eyes, and skin hives.
Loratadine competitively and selectively occupies H1 receptors before histamine can bind to them, preventing this inflammatory cascade. Because loratadine has a large molecular structure and low lipophilicity (low fat-solubility), it is poorly transported across the blood-brain barrier at standard therapeutic doses, explaining its significantly reduced sedation compared to first-generation antihistamines.
Interestingly, loratadine is actually a prodrug. After you take it, your liver converts it into its active form — descarboethoxyloratadine (also sold as desloratadine, brand name Clarinex) — which is responsible for most of the drug's antihistaminic activity. This metabolic conversion is carried out by liver enzymes called CYP3A4 and CYP2D6, which is why medications that inhibit these enzymes can cause drug interactions with Claritin.
---
## What Is Claritin Used For?
Seasonal Allergic Rhinitis (Hay Fever) Claritin is most commonly used for seasonal allergic rhinitis — the medical term for hay fever. It relieves sneezing, nasal itching, runny nose, and itchy, watery, or red eyes triggered by outdoor allergens such as tree pollen in spring, grass pollen in summer, and ragweed pollen in fall.
Perennial Allergic Rhinitis For patients allergic to year-round indoor allergens such as dust mites, cockroaches, mold, and animal dander, Claritin provides daily symptom control with minimal side effects from long-term use.
Chronic Idiopathic Urticaria (Hives) Claritin is FDA-approved for chronic idiopathic urticaria (CIU) — persistent hives lasting 6 weeks or longer without a clearly identified cause. It reduces the number, size, and itchiness of hive outbreaks. Clinical trials have demonstrated loratadine's efficacy in reducing CIU pruritus scores compared to placebo.
Allergic Conjunctivitis While not always listed as a primary indication, loratadine is clinically effective for the itching and redness of allergic conjunctivitis (eye allergies), especially when caused by systemic allergen exposure.
Other Uses Claritin is sometimes used off-label for pruritus associated with atopic dermatitis, drug-induced urticaria, and insect bite reactions, as well as prophylactically before allergen exposure.
---
## Claritin Dosage
Adults and Children 6 Years and Older The standard dose is 10 mg (one tablet, capsule, or RediTab) once daily. This dose should not be exceeded, as higher doses do not improve effectiveness and may increase adverse effects.
Children 2 to 5 Years The recommended dose is 5 mg (one teaspoon of syrup or one chewable tablet) once daily.
Hepatic or Renal Impairment Adults and children with liver disease or reduced kidney function (GFR below 30 mL/min) should take 10 mg every other day (every 48 hours) to prevent the drug from building up to excessive levels.
Claritin-D Claritin-D 12-Hour contains 5 mg loratadine + 120 mg pseudoephedrine sulfate, taken every 12 hours. Claritin-D 24-Hour contains 10 mg loratadine + 240 mg pseudoephedrine extended-release, taken once daily. Both versions must be purchased from behind the pharmacy counter.
Timing and Food Claritin can be taken with or without food. Food slightly increases bioavailability but this does not require any dose change. The orally disintegrating RediTab formulation dissolves on the tongue within seconds and does not require water, making it convenient for on-the-go use.
---
## Claritin Side Effects
Claritin is one of the best-tolerated antihistamines available, but no drug is entirely free of side effects.
Common Side Effects The most frequently reported side effects include headache (approximately 12%), drowsiness (8%), fatigue (4%), dry mouth (3%), nervousness (particularly in children, 4%), and nausea (2-3%). These are generally mild and often resolve as your body adjusts to the medication.
In Children Pediatric patients may experience nervousness, hyperactivity, abdominal pain, and nosebleeds more frequently than adults.
Serious Side Effects Although rare, serious allergic reactions to Claritin itself can occur, including anaphylaxis, severe angioedema, or bronchospasm. Stop taking Claritin and seek immediate medical attention if you experience throat swelling, difficulty breathing, chest tightness, or a severe skin rash.
Patients with significant liver disease may be at higher risk for adverse effects due to impaired loratadine metabolism.
Claritin-D Specific Concerns The pseudoephedrine in Claritin-D adds the risk of increased blood pressure, rapid or irregular heartbeat, insomnia, anxiety, and urinary difficulty. These risks are particularly important in patients with hypertension, heart disease, BPH, or thyroid conditions.
---
## Claritin Drug Interactions
Understanding Claritin drug interactions is important for safe use, particularly because loratadine is metabolized by liver enzymes that many other common medications also affect.
CYP3A4 Inhibitors Medications that inhibit the CYP3A4 liver enzyme can raise loratadine blood levels significantly. These include antifungals (ketoconazole, itraconazole, fluconazole), macrolide antibiotics (erythromycin, clarithromycin), and HIV protease inhibitors. When these drugs block CYP3A4, loratadine is metabolized more slowly and accumulates at higher concentrations, which can increase the risk of side effects including rare cardiac effects.
CYP2D6 Inhibitors Certain antidepressants — including fluoxetine (Prozac), paroxetine (Paxil), and bupropion (Wellbutrin) — inhibit the CYP2D6 enzyme, which also metabolizes loratadine. Concurrent use can elevate loratadine plasma levels moderately.
Cimetidine (Tagamet) This older heartburn drug inhibits both CYP3A4 and renal tubular secretion, raising loratadine AUC (overall exposure) by more than 100%. Patients taking cimetidine should use loratadine every other day or switch to a newer H2 blocker like famotidine.
Alcohol While Claritin alone rarely causes meaningful sedation, combining it with alcohol can enhance drowsiness and impair coordination and judgment. It is best to avoid alcohol or use it very cautiously while taking Claritin.
MAO Inhibitors (Claritin-D Only) The pseudoephedrine in Claritin-D is strictly contraindicated with monoamine oxidase inhibitors (MAOIs) such as phenelzine, tranylcypromine, and selegiline due to the risk of potentially fatal hypertensive crisis. A 14-day washout period is required before starting Claritin-D after stopping an MAOI.
Rifampin and Anticonvulsants Drugs that strongly induce CYP3A4 — such as rifampin, carbamazepine, and phenytoin — can accelerate loratadine metabolism and reduce its effectiveness. Patients on these medications may find Claritin less effective and should discuss alternative antihistamines with their doctor.
Grapefruit Juice Grapefruit and grapefruit juice contain compounds that inhibit intestinal CYP3A4, potentially increasing loratadine absorption. While this interaction is generally mild, it is wise to avoid large amounts of grapefruit during loratadine therapy.
---
## Warnings and Precautions
Do Not Use for Anaphylaxis Claritin is not a substitute for epinephrine in the treatment of anaphylaxis (severe, life-threatening allergic reactions). If you or someone near you experiences signs of anaphylaxis — throat swelling, severe difficulty breathing, a sudden drop in blood pressure, or loss of consciousness — administer epinephrine (EpiPen) immediately and call emergency services.
Phenylketonuria (PKU) Some Claritin chewable tablets and RediTab formulations contain aspartame, which releases phenylalanine upon metabolism. Patients with phenylketonuria (PKU) must check product labels and choose formulations that do not contain aspartame.
Liver and Kidney Disease Always inform your doctor if you have liver or kidney problems before taking Claritin. Both conditions require dose interval adjustment to avoid drug accumulation.
Driving and Machine Operation Although Claritin is classified as non-drowsy, approximately 1 in 12 users reports some degree of drowsiness. Patients should assess their individual response to the medication before driving or operating heavy machinery, particularly when starting treatment.
---
## Claritin During Pregnancy and Breastfeeding
Pregnancy Loratadine carries FDA Pregnancy Category B status. Multiple large epidemiological studies and post-marketing surveillance data have not found a significant association between loratadine use during pregnancy and major congenital malformations. It is generally considered one of the safer antihistamines to use during pregnancy when allergy symptoms require treatment. Always discuss the risks and benefits with your obstetrician before using any medication during pregnancy.
Breastfeeding Loratadine and desloratadine are excreted in breast milk in small amounts. The estimated relative infant dose is low (approximately 0.7% of the maternal dose). While most experts consider loratadine compatible with breastfeeding, particularly for older infants, discuss this with your doctor or a lactation consultant to make the best decision for you and your baby.
---
## Claritin Storage
Store Claritin tablets, capsules, and syrups at room temperature between 68°F and 77°F (20°C to 25°C). Protect from excessive moisture, heat, and direct sunlight. Do not store in the bathroom. Keep the medication in its original packaging until use. Orally disintegrating RediTabs must be stored in their blister packs to prevent premature dissolution from ambient humidity. Discard any medication that is past its expiration date. Keep all medications out of reach of children and pets.
---
## Claritin vs. Other Antihistamines
Patients often wonder how Claritin compares to other popular antihistamines such as Zyrtec (cetirizine) and Allegra (fexofenadine).
Claritin vs. Zyrtec Both are second-generation antihistamines, but cetirizine (Zyrtec) is somewhat more sedating than loratadine. Cetirizine may be slightly faster-acting and more potent for some patients. Head-to-head clinical trials have shown comparable efficacy for allergic rhinitis, though individual responses vary.
Claritin vs. Allegra Fexofenadine (Allegra) is generally considered the least sedating of the three major OTC second-generation antihistamines. It is not metabolized by CYP enzymes, so it has fewer drug interactions. However, its absorption is significantly reduced by fruit juices (orange, apple, grapefruit).
Claritin vs. Benadryl Diphenhydramine (Benadryl) is a first-generation antihistamine that is highly effective but causes significant sedation, dry mouth, urinary retention, and cognitive impairment. It should be avoided in elderly patients. For daily allergy management, second-generation antihistamines like Claritin are strongly preferred.
---
## Frequently Asked Questions
Is Claritin safe for long-term daily use? Yes. Claritin has a well-established safety profile for continuous daily use. Clinical trials and decades of post-marketing experience support its long-term safety. No tolerance or dependency develops with regular use.
Can I take Claritin at night instead of the morning? Yes, Claritin can be taken at any time of day. Some patients prefer taking it at night so that peak drug levels occur during waking hours the next morning. Others take it in the morning to align peak levels with daytime allergen exposure.
How does Claritin differ from Clarinex? Clarinex (desloratadine) is the active metabolite of loratadine. After you take Claritin, your body converts it to desloratadine in the liver. Clarinex is prescription-only, slightly more potent, and may be preferred for patients with hepatic impairment who cannot efficiently convert loratadine to its active form. Both drugs are effective second-generation antihistamines.
---
## Summary
Claritin (loratadine) is a safe, effective, and widely accessible second-generation antihistamine that provides once-daily relief from allergic rhinitis and chronic urticaria symptoms with minimal sedation. Its favorable drug interaction profile, low cost, and OTC availability make it one of the most prescribed allergy treatments worldwide. Understanding potential drug interactions — particularly with CYP3A4 inhibitors and, for Claritin-D, MAO inhibitors — is essential for safe use. Patients with liver or kidney disease should adjust dosing frequency, and all patients should be aware that Claritin does not treat anaphylaxis. For personalized allergy management, always consult a healthcare provider or licensed pharmacist.
Last reviewed by MedCentralHub Medical Review Board · MedCentralHub Editorial Policy
Medical Disclaimer
The information on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult your doctor, pharmacist, or qualified healthcare provider before starting, stopping, or changing any medication.